Literature DB >> 2297693

Retrospective analysis of the prognostic significance of DNA ploidy patterns and S-phase fraction in gastric carcinoma.

Y Yonemura1, S Ooyama, K Sugiyama, T Kamata, X De Aretxabala, H Kimura, T Kosaka, A Yamaguchi, K Miwa, I Miyazaki.   

Abstract

Paraffin-embedded tumor samples from 493 gastric carcinoma patients were analyzed by DNA flow cytometry. The results were correlated with clinicopathological findings and S-phase fractions measured by in vivo bromodeoxyuridine (BrdUrd) labeling. Of the 493 patients, 183 (37%), 225 (46%), and 85 (17%) showed diploidy, single DNA-aneuploidy, and DNA-multiploidy patterns, respectively. When the DNA histogram and all the clinicopathological parameters were entered simultaneously into the Cox regression model, DNA ploidy, liver metastasis, peritoneal dissemination, and nodal status emerged as independent prognostic parameters. The relative risk of death was twofold higher in single DNA-aneuploid and threefold higher in DNA-multiploid tumors than in DNA-diploid tumors. BrdUrd labeling indices (LIs) also proved to be an independent prognostic factor. Multiploid tumors showed the highest median BrdUrd LI associated with the most frequent peritoneal dissemination and liver metastasis. The simultaneous evaluation of DNA ploidy patterns and BrdUrd LIs gave more prognostic information than the determination of tumor DNA ploidy only. Namely, DNA diploid, together with low BrdUrd LIs, was associated with favorable prognosis, whereas DNA aneuploid with high BrdUrd LIs was related to the poorest prognosis. These results indicate that DNA ploidy and BrdUrd labeling indices may be possibly useful prognostic factors for gastric carcinoma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2297693

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

Review 1.  Clinical aspect and molecular mechanism of DNA aneuploidy in gastric cancers.

Authors:  Eiji Oki; Yuichi Hisamatsu; Koji Ando; Hiroshi Saeki; Yoshihiro Kakeji; Yoshihiko Maehara
Journal:  J Gastroenterol       Date:  2012-03-09       Impact factor: 7.527

2.  The prognostic significance of DNA ploidy in adenocarcinomas of the esophagogastric junction.

Authors:  M Sarbia; G Molsberger; R Willers; O Horstmann; C Schroders; R Porschen; E Gabbert H
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

3.  COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer.

Authors:  Johanna Mrena; Jan-Patrik Wiksten; Arto Kokkola; Stig Nordling; Ari Ristimäki; Caj Haglund
Journal:  Tumour Biol       Date:  2009-12-18

Review 4.  Clinical impact of aneuploidy on gastric cancer patients.

Authors:  Isabel Sánchez-Pérez; Pilar García Alonso; Cristóbal Belda Iniesta
Journal:  Clin Transl Oncol       Date:  2009-08       Impact factor: 3.405

5.  Influence of preoperative radiotherapy on DNA ploidy in squamous cell carcinomas of the oesophagus.

Authors:  R Porschen; G Bevers; U Remy; S Schauseil; F Borchard
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

6.  DNA ploidy and biologic aggressiveness of gastric adenocarcinoma in Chinese.

Authors:  K L Shen; C H Chu
Journal:  World J Surg       Date:  1994 May-Jun       Impact factor: 3.352

7.  DNA ploidy in early gastric carcinoma (T1): a flow cytometric study of 100 European cases.

Authors:  M J Brito; M I Filipe; G T Williams; H Thompson; M G Ormerod; J Titley
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

8.  Metastatic mode and DNA ploidy in gastric carcinoma.

Authors:  Y Umehara; T Kimura; M Yoshida; N Oba; Y Harada
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

9.  Independent clinical and flow cytometric prognostic factors for the survival of patients with stage I gastric cancer.

Authors:  Y Yonemura; S Ohoyama; H Kimura; H Matumoto; I Ninomiya; T Kosaka; A Yamaguchi; K Miwa; I Miyazaki
Journal:  Surg Today       Date:  1992       Impact factor: 2.549

10.  Metastatic mode of gastric carcinoma by flow cytometric and clinicopathologic parameters.

Authors:  Y Umehara; T Kimura; M Yoshida; N Oba; Y Harada
Journal:  Clin Exp Metastasis       Date:  1992-01       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.